We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$852M
AUM Growth
+$34.2M
Cap. Flow
-$2.21M
Cap. Flow %
-0.26%
Top 10 Hldgs %
41.05%
Holding
1,206
New
80
Increased
123
Reduced
188
Closed
61

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.02M
2
MSFT icon
Microsoft
MSFT
+$2.15M
3
META icon
Meta Platforms (Facebook)
META
+$1.41M
4
V icon
Visa
V
+$1.37M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$905K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.54M
2
KDP icon
Keurig Dr Pepper
KDP
+$3.78M
3
MON
Monsanto Co
MON
+$1.55M
4
VZ icon
Verizon
VZ
+$1.04M
5
PM icon
Philip Morris
PM
+$809K

Sector Composition

Rank Sector Weight
1 Financials 22.14%
2 Consumer Discretionary 16.55%
3 Technology 16.32%
4 Communication Services 12.04%
5 Healthcare 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDB icon
676
MongoDB
MDB
$35.9B
$19.9K ﹤0.01%
+400
New +$17.9K
VIAB
677
DELISTED
Viacom Inc. Class B
VIAB
$19.6K ﹤0.01%
650
-100
-13% -$2.94K
VEON icon
678
VEON
VEON
$4.19B
$19.5K ﹤0.01%
328
– –
SVM
679
Silvercorp Metals
SVM
$2.82B
$19.5K ﹤0.01%
7,300
– –
SGDM icon
680
Sprott Gold Miners ETF
SGDM
$734M
$19.3K ﹤0.01%
1,000
– –
STN icon
681
Stantec
STN
$8.41B
$19.2K ﹤0.01%
750
– –
VHT icon
682
Vanguard Health Care ETF
VHT
$19.3B
$19.1K ﹤0.01%
120
– –
PTLA
683
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$18.9K ﹤0.01%
500
– –
TBBK icon
684
The Bancorp
TBBK
$2.68B
$18.8K ﹤0.01%
+1,800
New +$19.8K
IPG
685
DELISTED
Interpublic Group of Companies
IPG
$18.8K ﹤0.01%
802
– –
CG icon
686
Carlyle Group
CG
$17.5B
$18.7K ﹤0.01%
+879
New +$18.9K
APA icon
687
APA Corp
APA
$14.9B
$18.7K ﹤0.01%
400
– –
DVN icon
688
Devon Energy
DVN
$52.1B
$18.7K ﹤0.01%
425
– –
TECK icon
689
Teck Resources
TECK
$34B
$18.6K ﹤0.01%
731
– –
PSQ icon
690
ProShares Short QQQ
PSQ
$598M
$18.6K ﹤0.01%
117
– –
BCPC
691
Balchem Corp
BCPC
$5.69B
$18.5K ﹤0.01%
189
– –
BLDP
692
Ballard Power Systems
BLDP
$678M
$18.5K ﹤0.01%
6,500
-3,300
-34% -$10.4K
PRTA icon
693
Prothena Corp
PRTA
$479M
$18.5K ﹤0.01%
1,269
+936
+281% +$18.5K
IRTC icon
694
iRhythm Holdings
IRTC
$3.96B
$18.3K ﹤0.01%
225
– –
ICF icon
695
iShares Select U.S. REIT ETF
ICF
$2.08B
$18.2K ﹤0.01%
364
– –
INWK
696
DELISTED
InnerWorkings, Inc.
INWK
$18K ﹤0.01%
2,077
– –
CBUS icon
697
Cibus
CBUS
$126M
$18K ﹤0.01%
19
+1
+6% +$861
LXRX icon
698
Lexicon Pharmaceuticals
LXRX
$1.02B
$18K ﹤0.01%
1,500
– –
FCFS icon
699
FirstCash
FCFS
$9.51B
$18K ﹤0.01%
200
– –
CERN
700
DELISTED
Cerner Corp
CERN
$17.9K ﹤0.01%
300
– –
26 27
28
29 30

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q2 2018 Portfolio in Review

As of Q2 2018, RBC Europe held 1,206 positions worth $852M, up 4.2% from $817M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

RBC Europe's Q2 2018 filing shows 80 new, 123 increased, 188 reduced and 61 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K. The largest sale was Celgene Corp, an estimated $4.54M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q2 2018 buy was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2018, an estimated $4.02M increase.
  • RBC Europe's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $4.54M.
  • RBC Europe fully exited Monsanto Co in Q2 2018, selling an estimated $1.55M.
  • RBC Europe's ten largest holdings make up 41% of its $852M portfolio in Q2 2018.
  • RBC Europe opened 80 new positions and closed 61 in Q2 2018.
  • RBC Europe's portfolio value rose 4.2% quarter-over-quarter to $852M.

Based on RBC Europe's 13F filing for Q2 2018, filed 9 Nov 2023.